Trigemina Overview

  • Founded
  • 2006
Founded
  • Status
  • Out of Business
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Out of Business

Trigemina General Information

Description

Developer of non-narcotic analgesic drug products intended to develop novel, non-opioid, non-sedating, cognition neutral neurological therapies. The company's drugs are made up of novel naso-cerebral formulations for pain therapy that are delivered to through the nasal-cerebral pathway, enabling people to get relief from chronic migraine and other neuropathic pain.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
  • 1036 Country Club Drive
  • Suite 200
  • Moraga, CA 94556
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Trigemina Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Out of Business 05-Aug-2020 00.000 Completed Out of Business
7. Later Stage VC (Series A1) 14-Apr-2014 00.00 00.000 Completed Generating Revenue
6. Grant 17-Jun-2013 00.000 Completed Generating Revenue
5. Later Stage VC 12-Apr-2012 00.000 Completed Generating Revenue
4. Convertible Debt 17-Nov-2010 00000 00.000 Completed Startup
3. Early Stage VC 17-Nov-2010 00000 00.000 Completed Startup
2. Grant 01-Jan-2009 $444K $2.41M Completed Startup
1. Early Stage VC (Series A) 09-May-2007 $2.41M $2.41M Completed Startup
To view Trigemina’s complete valuation and funding history, request access »

Trigemina Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of non-narcotic analgesic drug products intended to develop novel, non-opioid, non-sedating, cognition neutral
Drug Discovery
Moraga, CA
12 As of 2015
00.000
00000000 00 00.000

0000000

um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000 000000000
Woods Cross, UT
0 As of 0000
00000
00.00 0000-00-00
000000000000 00000

00000000

um dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qu
0000 000000000
Bridgewater, NJ
0 As of 0000
00.00 0000-00-00
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trigemina Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Phoenix Pharmalabs Angel-Backed Woods Cross, UT 0 00000 000000000000 00000
00000000 Angel-Backed Bridgewater, NJ 0 000000000000
You’re viewing 2 of 2 competitors. Get the full list »

Trigemina Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial